BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16208531)

  • 1. Relationship and prognostic significance of phospho-(serine 166)-murine double minute 2 and Akt activation in node-negative breast cancer with regard to p53 expression.
    Schmitz KJ; Grabellus F; Callies R; Wohlschlaeger J; Otterbach F; Kimmig R; Levkau B; Schmid KW; Baba HA
    Virchows Arch; 2006 Jan; 448(1):16-23. PubMed ID: 16208531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathways.
    Li H; Wang Z; Jiang M; Fang RP; Shi H; Shen Y; Cai XL; Liu Q; Ye K; Fan SJ; Zhang WY; Ye LH
    Acta Pharmacol Sin; 2018 Nov; 39(11):1787-1796. PubMed ID: 30181579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of PI3K /Akt /mdm2 signaling pathway on the sensitivity of gastric cancer cell line SGC7901 to doxorubicin].
    Ai YW; Yu HG; Yu JP; Yang Y; Li H; Hu XW; Luo HS
    Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):494-7. PubMed ID: 19062713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
    Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
    Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer.
    Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
    Histopathology; 2014 Mar; 64(4):523-35. PubMed ID: 24289472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MEK-ERK-mediated phosphorylation of Mdm2 at Ser-166 in hepatocytes. Mdm2 is activated in response to inhibited Akt signaling.
    Malmlöf M; Roudier E; Högberg J; Stenius U
    J Biol Chem; 2007 Jan; 282(4):2288-96. PubMed ID: 17107963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers.
    Abdel-Fatah TM; Powe DG; Agboola J; Adamowicz-Brice M; Blamey RW; Lopez-Garcia MA; Green AR; Reis-Filho JS; Ellis IO
    J Pathol; 2010 Mar; 220(4):419-34. PubMed ID: 20044801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
    Park SS; Kim SW
    Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
    Liu K; Xue B; Bai G; Zhang W
    Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C epsilon confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53.
    Shankar E; Sivaprasad U; Basu A
    Oncogene; 2008 Jun; 27(28):3957-66. PubMed ID: 18317451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wild-type p53 breast cancer cells.
    Geng QQ; Dong DF; Chen NZ; Wu YY; Li EX; Wang J; Wang SM
    Int J Oncol; 2013 Dec; 43(6):1935-42. PubMed ID: 24126697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of p16INK4a/p53 in Tunisian patients with breast carcinoma.
    Karray-Chouayekh S; Baccouche S; Khabir A; Sellami-Boudawara T; Daoud J; Frikha M; Jlidi R; Gargouri A; Mokdad-Gargouri R
    Acta Histochem; 2011 Sep; 113(5):508-13. PubMed ID: 20598349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia trachomatis plasmid-encoded protein Pgp3 inhibits apoptosis via the PI3K-AKT-mediated MDM2-p53 axis.
    Zou Y; Lei W; Su S; Bu J; Zhu S; Huang Q; Li Z
    Mol Cell Biochem; 2019 Feb; 452(1-2):167-176. PubMed ID: 30132214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preconditioning-Activated AKT Controls Neuronal Tolerance to Ischemia through the MDM2-p53 Pathway.
    Barrio E; Vecino R; Sánchez-Morán I; Rodríguez C; Suárez-Pindado A; Bolaños JP; Almeida A; Delgado-Esteban M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDM2, P53, P21WAF1 and pAKT protein levels in genesis and behaviour of adenoid cystic carcinoma.
    de Lima Mde D; Marques YM; Alves Sde M; Freitas VM; Soares FA; de Araújo VC; Pinto Ddos S; Mantesso A
    Cancer Epidemiol; 2009 Aug; 33(2):142-6. PubMed ID: 19679062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of murine double minute 2 is a favorable prognostic marker in esophageal squamous cell carcinoma without p53 protein accumulation.
    Saito H; Tsujitani S; Oka S; Ikeguchi M; Maeta M; Kaibara N
    Ann Surg Oncol; 2002 Jun; 9(5):450-6. PubMed ID: 12052755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated Akt expression in breast cancer: correlation with p53, Hdm2 and patient outcome.
    Vestey SB; Sen C; Calder CJ; Perks CM; Pignatelli M; Winters ZE
    Eur J Cancer; 2005 May; 41(7):1017-25. PubMed ID: 15862750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori Infection Activates the Akt-Mdm2-p53 Signaling Pathway in Gastric Epithelial Cells.
    Shu X; Yang Z; Li ZH; Chen L; Zhou XD; Xie Y; Lu NH
    Dig Dis Sci; 2015 Apr; 60(4):876-86. PubMed ID: 25480405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mdm2, p53, p21 and pAKT protein pathways in benign neoplasms of the salivary gland.
    Marques YM; de Lima Mde D; de Melo Alves Sde M; Soares FA; de Araújo VC; Pinto Ddos S; Mantesso A
    Oral Oncol; 2008 Sep; 44(9):903-8. PubMed ID: 18485798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.